PharmaCyte Biotech, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Las Vegas, NV
SEC filing record 1 source field available
Fiscal year end
30 April
PharmaCyte Biotech, Inc. has filed 469 SEC EDGAR filings since 20 Aug 2001

SEC filing history

Showing 76-100 of 389 matching filings.

Per page
25
Current page
4
4

4 filing

Filing date
22 Nov 2023
Reporting date
20 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Nov 2023
Reporting date
20 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Nov 2023
Reporting date
20 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Nov 2023
Reporting date
20 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Nov 2023
Reporting date
20 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D

FORM SC-13D

Filing date
22 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40699

CURRENT REPORT

Filing date
16 Nov 2023
Reporting date
14 Nov 2023
Next action
Verify source filing
8-K File 001-40699

CURRENT REPORT

Filing date
09 Nov 2023
Reporting date
05 Nov 2023
Next action
Verify source filing
EFFECT File 333-272569

EFFECT filing

Filing date
29 Sep 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
27 Sep 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 001-40699

FORM 12B-25

Filing date
15 Sep 2023
Reporting date
31 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3/A File 333-272569

AMENDMENT 2

Filing date
12 Sep 2023
Reporting date
Not listed
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
04 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3/A File 333-272569

AMENDMENT NO. 1

Filing date
04 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-40699

ANNUAL REPORT

Filing date
31 Jul 2023
Reporting date
30 Apr 2023
Next action
Verify source filing
DEF 14A File 001-40699

DEFINITIVE PROXY

Filing date
31 Jul 2023
Reporting date
31 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-40699

PRELIMINARY PROXY STATEMENT

Filing date
19 Jul 2023
Reporting date
31 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40699

CURRENT REPORT

Filing date
19 Jul 2023
Reporting date
14 Jul 2023
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
26 Jun 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91495

SC 13D/A filing

Filing date
16 Jun 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC TO-I/A File 005-91495

SC TO-I/A

Filing date
15 Jun 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .